Cover Image
市場調查報告書

Phosphagenics Limited:產品平台分析

Phosphagenics Limited - Product Pipeline Review - 2014

出版商 Global Markets Direct 商品編碼 224665
出版日期 內容資訊 英文 38 Pages
訂單完成後即時交付
價格
Back to Top
Phosphagenics Limited:產品平台分析 Phosphagenics Limited - Product Pipeline Review - 2014
出版日期: 2014年12月10日 內容資訊: 英文 38 Pages
簡介

Phosphagenics Limited是醫藥品及機能性食品的原料廠商。 主要致力於開發提升已經過實証有效的機能性食品及醫藥產品遞送到人體的技術、解決方案,不僅只人類,該公司同時也製造動物用營養補助食品、機能食品及飲料用原料。該公司的技術是以基於磷酸維生素 (TPM) 傳送系統的獨家藥物送系統為核心,藉由該方法可由皮膚遞送藥劑。

本報告提供Phosphagenics Limited的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

Phosphagenics Limited的基本資料

  • Phosphagenics Limited概要
  • 主要資訊
  • 企業資料

Phosphagenics Limited :R&D概要

  • 主要的治療範圍

Phosphagenics Limited :開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

Phosphagenics Limited :開發中產品概況

  • 臨床實驗階段的開發中產品
    • 第二階段的產品/聯合治療模式
    • 第一階段的產品/聯合治療模式
  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式
    • 藥物研發中的產品/聯合治療模式

Phosphagenics Limited :藥物簡介

  • tretinoin
  • ketoconazole
  • lidocaine
  • oxycodone ER
  • oxymorphone hydrochloride
  • diclofenac sodium
  • Drug for Acne
  • propofol
  • Proteins for Undisclosed Indication

Phosphagenics Limited :開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Phosphagenics Limited :最近的開發平台趨勢

Phosphagenics Limited :暫停中的計劃

Phosphagenics Limited :企業發表

Phosphagenics Limited :總公司和子公司的所在地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC06631CDB

Summary

Global Markets Direct's, 'Phosphagenics Limited - Product Pipeline Review - 2014', provides an overview of the Phosphagenics Limited's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Phosphagenics Limited's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Phosphagenics Limited including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Phosphagenics Limited's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Phosphagenics Limited's pipeline products

Reasons to buy

  • Evaluate Phosphagenics Limited's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Phosphagenics Limited in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Phosphagenics Limited's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Phosphagenics Limited and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Phosphagenics Limited
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Phosphagenics Limited and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Phosphagenics Limited Snapshot
    • Phosphagenics Limited Overview
    • Key Information
    • Key Facts
  • Phosphagenics Limited - Research and Development Overview
    • Key Therapeutic Areas
  • Phosphagenics Limited - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Phosphagenics Limited - Pipeline Products Glance
    • Phosphagenics Limited - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
    • Phosphagenics Limited - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Phosphagenics Limited - Drug Profiles
    • tretinoin
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ketoconazole
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • lidocaine
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • oxycodone ER
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • oxymorphone hydrochloride
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • diclofenac sodium
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Drug for Acne
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • propofol
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Proteins for Undisclosed Indication
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Phosphagenics Limited - Pipeline Analysis
    • Phosphagenics Limited - Pipeline Products by Target
    • Phosphagenics Limited - Pipeline Products by Route of Administration
    • Phosphagenics Limited - Pipeline Products by Molecule Type
    • Phosphagenics Limited - Pipeline Products by Mechanism of Action
  • Phosphagenics Limited - Recent Pipeline Updates
  • Phosphagenics Limited - Dormant Projects
  • Phosphagenics Limited - Company Statement
  • Phosphagenics Limited - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Phosphagenics Limited, Key Information
  • Phosphagenics Limited, Key Facts
  • Phosphagenics Limited - Pipeline by Indication, 2014
  • Phosphagenics Limited - Pipeline by Stage of Development, 2014
  • Phosphagenics Limited - Monotherapy Products in Pipeline, 2014
  • Phosphagenics Limited - Phase II, 2014
  • Phosphagenics Limited - Phase I, 2014
  • Phosphagenics Limited - Preclinical, 2014
  • Phosphagenics Limited - Discovery, 2014
  • Phosphagenics Limited - Pipeline by Target, 2014
  • Phosphagenics Limited - Pipeline by Route of Administration, 2014
  • Phosphagenics Limited - Pipeline by Molecule Type, 2014
  • Phosphagenics Limited - Pipeline Products by Mechanism of Action, 2014
  • Phosphagenics Limited - Recent Pipeline Updates, 2014
  • Phosphagenics Limited - Dormant Developmental Projects,2014
  • Phosphagenics Limited, Other Locations
  • Phosphagenics Limited, Subsidiaries

List of Figures

  • Phosphagenics Limited - Pipeline by Top 10 Indication, 2014
  • Phosphagenics Limited - Pipeline by Stage of Development, 2014
  • Phosphagenics Limited - Monotherapy Products in Pipeline, 2014
  • Phosphagenics Limited - Pipeline by Top 10 Target, 2014
  • Phosphagenics Limited - Pipeline by Top 10 Route of Administration, 2014
  • Phosphagenics Limited - Pipeline by Top 10 Molecule Type, 2014
  • Phosphagenics Limited - Pipeline Products by Top 10 Mechanism of Action, 2014
Back to Top